Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0101
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2009
Authors
Publisher
American Association for Cancer Research (AACR)